Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Patients and their families have been fully informed about the study and have voluntarily agreed to take part by signing a consent form.
- People aged between 18 and 75 years old (including those who are exactly 18 or 75).
- People who have been diagnosed through tissue testing with advanced stomach cancer (specifically cancer in the lower part of the stomach, classified as stage IV) that has spread locally or to distant parts of the body or the lining of the abdomen, and where surgery to fully remove the cancer is not possible.
- People who have a blockage in their digestive tract (confirmed by X-ray or a camera examination of the stomach), with a low score on a scale used to measure how well food and liquid can pass through (GOOSS score of 1 or below).
- People whose general physical condition and ability to carry out daily activities falls within a certain range on a standard medical scale (ECOG score of 0–2), and this has been stable for at least 7 days.
- People whose overall surgical risk falls within a certain accepted range on a standard assessment scale (ASA score of I to III).
- People who have not previously received any anti-cancer treatment, such as radiation, chemotherapy, targeted therapy, or immunotherapy.
- People whose key organ functions meet specific blood and laboratory test requirements, including healthy enough levels of blood cells, liver function, kidney function, heart function, and blood clotting ability (confirm specific values with the trial site).
- Women who are able to become pregnant must be using effective contraception.
- People who have no other medical reasons that would make surgery unsafe.
- People who are willing and able to attend follow-up appointments and cooperate with the study requirements.
Who may not be able to join:
- People who are unable or unwilling to follow the study plan or its procedures.
- People who have had another type of cancer in the past 5 years, except for certain skin cancers or early-stage cervical cancer that were fully treated with surgery.
- People who have an active autoimmune disease (where the immune system attacks the body), or who have had one in the 4 weeks before joining the study.
- People who have previously had a bone marrow transplant or an organ transplant from another person.
- People who have had a serious heart condition in the past 6 months, such as a heart attack, severe chest pain, heart bypass surgery, or significant heart failure, or who have an irregular heartbeat requiring medication, or whose heart pumping strength falls below a certain level.
- People who have a serious active infection that is not under control.
- People known to have HIV, active hepatitis B, or active hepatitis C infection (as determined by specific blood test results — confirm details with the trial site).
- People who are pregnant (confirmed by a test before treatment) or who are currently breastfeeding.
- People who have any other serious medical condition, unusual test results, or health situation that the research doctors believe would make participation unsafe or affect the study's results.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +867715310421
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of delayed gastric emptying(DGE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.